Lytic Induction Therapy against Epstein–Barr Virus-Associated Malignancies: Past, Present, and Future

Epstein–Barr virus (EBV) lytic induction therapy is an emerging virus-targeted therapeutic approach that exploits the presence of EBV in tumor cells to confer specific killing effects against EBV-associated malignancies. Efforts have been made in the past years to uncover the mechanisms of EBV laten...

Descripción completa

Detalles Bibliográficos
Autores principales: Yiu, Stephanie Pei Tung, Dorothea, Mike, Hui, Kwai Fung, Chiang, Alan Kwok Shing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465660/
https://www.ncbi.nlm.nih.gov/pubmed/32748879
http://dx.doi.org/10.3390/cancers12082142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465660/
https://www.ncbi.nlm.nih.gov/pubmed/32748879
http://dx.doi.org/10.3390/cancers12082142

Ejemplares similares